DJIA 18,162.99 121.45 0.67%
NASDAQ 5,106.59 73.84 1.47%
S&P 500 2,123.48 19.28 0.92%
market minute promo

Novartis (NYSE: NVS)



company name or ticker
Company Photos
(Click to zoom)

Stocks To Buy For 10 Years: Facebook Inc, Amazon.com, Inc, and Google Inc.

Patient tech investors should buy and hold Facebook, Amazon, and Google for at least the next ten years.

Billionaire George Soros Just Sold These 3 Stocks: Should You?

The Soros Fund Management sold Kite Pharma, Valeant Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. in the first quarter. Should you follow in its footsteps?

Will Competition Cause Teva Pharmaceutical Industries ltd. To Tumble?

The FDA has approved Novartis' biosimilar to Teva Pharmaceuticals' Copaxone.

Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog

Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog

Novartis Reports Two Positive US Phase III Programs in COPD for QVA149, NVA237

Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 21, 2015

Biosimilars Vs Generics: History Does Not Repeat, It Rhymes

Could This Be Healthcare's $158 Billion Black Swan Event?

This unlikely event is becoming increasingly more likely -- and the impact would be enormous.

2 Stocks With Jaw-Dropping Growth Potential

These 2 companies are high-risk investments, but they nonetheless have the potential to become pivotal players in the rapidly expanding field of immuno-oncology. Here's why.

Baxter Takes The Acquisition Route To Grow In The Oncology Segment

See More Articles...